Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Agenus Inc completes acquisition of 4-Antibody


Thursday, 13 Feb 2014 07:00am EST 

Agenus Inc:Completes the previously announced acquisition of 4-Antibody AG, a private European-based biopharmaceutical company.Agenus acquired all outstanding stock of 4-Antibody for about 3.3 million shares of Agenus common stock, plus additional contingent payments, payable in cash or Agenus common stock, that may exceed $40 million based on the combined company achieving certain milestones. 

Company Quote

3.08
0.08 +2.67%
4:00pm EDT